Home » Newsletters » BioWorld Science

BioWorld Science

June 30, 2017

View Archived Issues

Crestovo initiates phase III trial of CP-101 to prevent C. difficile infection

KemPharm reveals new ADHD candidate

KIAA0125 found as an unfavorable prognostic marker in acute myeloid leukemia

New zebrafish Fanconi anemia-like model developed

FDA grants orphan drug designation for ABO-201 juvenile Batten disease gene therapy program

Alcyone Lifesciences and Pfizer enter feasibility study agreement

Gene-edited hematopoietic stem/progenitor cells created for SCID-X1

Paion completes phase III program for remimazolam for procedural sedation

Alkermes reports phase III data on ALKS-3831 in schizophrenia

Auspherix patents gold complexes for treating bacterial infections

Endpoints met in Lee's phase Ib/IIa study of adapalene/clindamycin gel for acne

Merck & Co. presents oxysterols receptor LXR-beta agonists

FORWARD II finds mirvetuximab soravtansine safe in combination therapies for ovarian cancer

Luc Therapeutics discloses NMDA receptor modulators

Research Triangle Institute divulges apelin receptor agonists

Janssen Pharmaceutica discovers BTK inhibitors

Cara Therapeutics reports phase IIb topline results on oral CR-845 for osteoarthritis pain

Heptares Therapeutics and PeptiDream enter inflammatory disease collaboration

Windtree reports topline phase IIb results for Aerosurf to treat RDS in premature infants

Sanpower Group completes Dendreon acquisition

FDA grants orphan drug designation to ganaxolone for CDKL5 disorder

FDA seeks to eliminate orphan drug designation request backlog

Acorda submits NDA for Inbrija to treat off episodes in Parkinson's disease

miR15a-5p identified as a biomarker of recurrence in colorectal carcinoma

Polatuzumab vedotin is eligible for access to EMA's PRIME program

Eiger Biopharmaceuticals selling Mydicar to Theragene Pharmaceuticals

FDA grants QIDP designation to Amphora for gonorrhea and bacterial vaginosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...